TOTAL NUCLEAR ANTIBODY FOR HEPATITIS B VIRUS (ANTI-HBCAG) - ANVISA Registration 10009010463

Access comprehensive regulatory information for TOTAL NUCLEAR ANTIBODY FOR HEPATITIS B VIRUS (ANTI-HBCAG) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10009010463 and manufactured by LABTEST DIAGNOSTICA S/A. The registration is held by LABTEST DIAGNOSTICA S/A with validity until Oct 21, 2034.

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT GMBH, SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LTD., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.